Szokol Joseph W
University of Chicago, Pritzker School of Medicine, Chicago, Illinois, USA.
Semin Cardiothorac Vasc Anesth. 2010 Mar;14(1):73-4. doi: 10.1177/1089253210362795.
Heparin-induced thrombocytopenia (HIT) is an antibody-mediated reaction caused by exposure to heparin that can lead to devastating thrombotic complications. HIT usually occurs 5 to 10 days after exposure to heparin but can happen more rapidly to patients who are reexposed to heparin within 100 days. The hallmark of this disorder is a sudden drop in platelet count of greater than 50%. Once HIT is suspected the heparin must be immediately discontinued and an anticoagulant (direct thrombin inhibitor or heparinoid) started. For patients presenting for cardiac surgery and cardiopulmonary bypass that have a history of HIT and positive antibodies a direct thrombin inhibitor such as lepirudin, argatroban or bivalirudin must be used in lieu of heparin.
肝素诱导的血小板减少症(HIT)是一种由接触肝素引起的抗体介导反应,可导致严重的血栓形成并发症。HIT通常在接触肝素后5至10天发生,但对于在100天内再次接触肝素的患者,可能会更快出现。这种疾病的标志是血小板计数突然下降超过50%。一旦怀疑HIT,必须立即停用肝素,并开始使用抗凝剂(直接凝血酶抑制剂或类肝素)。对于有HIT病史且抗体呈阳性的心脏手术和体外循环患者,必须使用直接凝血酶抑制剂,如比伐卢定、阿加曲班或水蛭素,以替代肝素。